News
A new drug from California-based pharma company Amgen, which has concluded a phase II trial, shows promise as a powerful ...
The new weight loss drug which is set to give Ozempic and Mounjaro a run for their money, MariTide, is taken on a monthly ...
Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects and discontinuations in a ...
While Amgen’s monthly obesity candidate MariTide helped patients lose significant amounts of weight in a phase 2 study, ...
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
Full Phase 2 study results showed side effects that led people to stop treatment with MariTide, as well as weight loss ...
Thousand Oaks, California Wednesday, June 25, 2025, 13:00 Hrs [IST] ...
New once-a-month drug could treat diabetes and obesity, scientists say - Researchers say experimental drug’s less frequent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results